Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8554 + SHR0410 for postoperative abdominal pain
CTR20221834Phase 2Terminated
- Sponsor
- Hengrui Therapeutics
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegileridine, SHR0410 in postoperative pain, sponsored by Hengrui Therapeutics. Started Jul 2022; status: terminated.
02
Drugs
tegileridineSHR0410
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221834.